Hyperprolactinemia is a Major Problem in Patients Treated with Antipsychotic Drugs

被引：0
|
作者：
Baskoy, Kamil [1 ]
Ay, Seyid Ahmet [1 ]
Deniz, Ferhat [1 ]
Yonem, Arif [1 ]
机构：
[1] Haydarpasha Training Hosp, Gulhane Mil Med Fac, Dept Endocrinol & Metab, Istanbul, Turkey
来源：
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2016年 / 26卷 / 02期
关键词：
hyperprolactinemia; antipsychotic; endocrinology;
D O I：
10.5455/bcp.20151209125410
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：210 / 211
页数：2
相关论文
共 50 条
  • [21] Hyperprolactinemia during antipsychotic drug treatment in elderly patients
    Kinon, BJ
    Wang, L
    Stauffer, VL
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 42S - 42S
  • [22] A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents
    Saito, E
    Correll, CU
    Gallelli, K
    McMeniman, M
    Parikh, UH
    Malhotra, AK
    Kafantaris, V
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2004, 14 (03) : 350 - 358
  • [23] Antipsychotic-induced hyperprolactinemia in a sample of psychotic patients
    Fernandez-Quintana, A.
    Garcia Mahia, M. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S962 - S962
  • [24] The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
    Ivanova, Svetlana
    Boiko, Anastasia
    Bokhan, Nikolay
    Fedorenko, Olga
    Freidin, Maxim
    Loonen, Anton
    Osmanova, Diana
    Pozhidaev, Ivan
    Semke, Arkadiy
    Wilffert, Bob
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 236 - 236
  • [25] Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
    Bardenshtein, L. M.
    Mkrtumyan, A. M.
    Aleshkina, G. A.
    DIABETES MELLITUS, 2010, 13 (02): : 42 - 44
  • [26] Antipsychotic, hyperprolactinemia and quality of life
    Scaramozzino, S.
    Caraby, I.
    Benlahcene, N.
    Tranape, M.
    Cuvelier, K.
    EUROPEAN PSYCHIATRY, 2014, 29 (08) : 649 - 649
  • [27] Antipsychotic-induced hyperprolactinemia
    Khouadja, S.
    Ben Soussia, R.
    Bouallagui, A.
    Marrag, I.
    Younes, S.
    Nasr, M.
    EUROPEAN PSYCHIATRY, 2017, 41 : S701 - S701
  • [28] PHARMACOTHERAPY Valvulopathy in patients treated for hyperprolactinemia?
    Droogmans, Steven
    Van Camp, Guy
    NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (07) : 357 - 358
  • [29] Hyperprolactinemia during antipsychotic drug treatment in elderly patients.
    Kinon, BJ
    Stauffer, VL
    Wang, L
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S46 - S46
  • [30] Hyperprolactinemia and sexual side effects in children and adolescents treated with atypical antipsychotic agents
    Saito, E
    Correll, CU
    Kafantaris, V
    Gallelli, K
    McMeniman, M
    Parikh, UH
    Malhotra, AK
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 42S - 42S
12345